Plan B OTC Switch Decision Deadline Is Sept. 1, HHS’ Leavitt Says
This article was originally published in The Tan Sheet
Executive Summary
Two Democratic senators have lifted their hold on the nomination of FDA Acting Commissioner Lester Crawford to the permanent post following HHS confirmation that FDA will act on the Plan B OTC switch application by Sept. 1